vs
Fortress Biotech, Inc.（FBIO）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
Fortress Biotech, Inc.的季度营收约是RIVERVIEW BANCORP INC的1.1倍（$16.1M vs $14.0M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -24.5%，领先34.3%），RIVERVIEW BANCORP INC同比增速更快（10.4% vs 6.3%），过去两年RIVERVIEW BANCORP INC的营收复合增速更高（24.6% vs 11.0%）
堡垒生物科技（Fortress Biotech）是一家生物制药企业，核心业务为收购、开发并商业化创新医药与生物技术产品。公司由医学博士林赛·A·罗森瓦尔德担任首席执行官，包括绝大多数子公司在内，公司总部均设于佛罗里达州贝港群岛。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
FBIO vs RVSB — 直观对比
营收规模更大
FBIO
是对方的1.1倍
$14.0M
营收增速更快
RVSB
高出4.1%
6.3%
净利率更高
RVSB
高出34.3%
-24.5%
两年增速更快
RVSB
近两年复合增速
11.0%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $16.1M | $14.0M |
| 净利润 | $-3.9M | $1.4M |
| 毛利率 | 66.1% | — |
| 营业利润率 | -28.8% | 12.4% |
| 净利率 | -24.5% | 9.8% |
| 营收同比 | 6.3% | 10.4% |
| 净利润同比 | 41.8% | 11.8% |
| 每股收益（稀释后） | $-0.15 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FBIORVSB
| Q4 25 | $16.1M | $14.0M | ||
| Q3 25 | $17.6M | $13.6M | ||
| Q2 25 | $16.4M | $13.3M | ||
| Q1 25 | $13.1M | $12.9M | ||
| Q4 24 | $15.1M | $12.7M | ||
| Q3 24 | $14.6M | $12.8M | ||
| Q2 24 | $14.9M | $12.2M | ||
| Q1 24 | $13.0M | $9.0M |
净利润FBIORVSB
| Q4 25 | $-3.9M | $1.4M | ||
| Q3 25 | $5.8M | $1.1M | ||
| Q2 25 | $15.5M | $1.2M | ||
| Q1 25 | $-10.6M | $1.1M | ||
| Q4 24 | $-6.8M | $1.2M | ||
| Q3 24 | $-12.9M | $1.6M | ||
| Q2 24 | $-10.9M | $966.0K | ||
| Q1 24 | $-15.4M | $-3.0M |
毛利率FBIORVSB
| Q4 25 | 66.1% | — | ||
| Q3 25 | 67.4% | — | ||
| Q2 25 | 69.9% | — | ||
| Q1 25 | 63.5% | — | ||
| Q4 24 | 69.1% | — | ||
| Q3 24 | 69.4% | — | ||
| Q2 24 | 61.6% | — | ||
| Q1 24 | 53.9% | — |
营业利润率FBIORVSB
| Q4 25 | -28.8% | 12.4% | ||
| Q3 25 | -38.6% | 10.2% | ||
| Q2 25 | -222.2% | 11.7% | ||
| Q1 25 | -169.9% | 11.3% | ||
| Q4 24 | -158.3% | 12.4% | ||
| Q3 24 | -151.0% | 15.5% | ||
| Q2 24 | -186.5% | 10.0% | ||
| Q1 24 | -280.6% | -47.5% |
净利率FBIORVSB
| Q4 25 | -24.5% | 9.8% | ||
| Q3 25 | 33.2% | 8.1% | ||
| Q2 25 | 94.4% | 9.2% | ||
| Q1 25 | -80.6% | 8.9% | ||
| Q4 24 | -44.7% | 9.7% | ||
| Q3 24 | -88.0% | 12.2% | ||
| Q2 24 | -73.5% | 7.9% | ||
| Q1 24 | -118.3% | -34.7% |
每股收益（稀释后）FBIORVSB
| Q4 25 | $-0.15 | $0.07 | ||
| Q3 25 | $0.11 | $0.05 | ||
| Q2 25 | $0.45 | $0.06 | ||
| Q1 25 | $-0.48 | $0.05 | ||
| Q4 24 | $-0.16 | $0.06 | ||
| Q3 24 | $-0.76 | $0.07 | ||
| Q2 24 | $-0.73 | $0.05 | ||
| Q1 24 | $-1.04 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $79.4M | $28.6M |
| 总债务越低越好 | $52.4M | — |
| 股东权益账面价值 | $49.9M | $164.2M |
| 总资产 | $185.5M | $1.5B |
| 负债/权益比越低杠杆越低 | 1.05× | — |
8季度趋势，按日历期对齐
现金及短期投资FBIORVSB
| Q4 25 | $79.4M | $28.6M | ||
| Q3 25 | $86.2M | $32.8M | ||
| Q2 25 | $74.4M | $34.2M | ||
| Q1 25 | $91.3M | $29.4M | ||
| Q4 24 | $57.3M | $25.3M | ||
| Q3 24 | $58.9M | $31.0M | ||
| Q2 24 | $76.2M | $27.8M | ||
| Q1 24 | $83.8M | $23.6M |
总债务FBIORVSB
| Q4 25 | $52.4M | — | ||
| Q3 25 | $47.8M | — | ||
| Q2 25 | $50.0M | — | ||
| Q1 25 | $56.4M | — | ||
| Q4 24 | $58.0M | — | ||
| Q3 24 | $52.5M | — | ||
| Q2 24 | $67.0M | — | ||
| Q1 24 | $61.4M | — |
股东权益FBIORVSB
| Q4 25 | $49.9M | $164.2M | ||
| Q3 25 | $55.9M | $163.5M | ||
| Q2 25 | $43.9M | $162.0M | ||
| Q1 25 | $22.3M | $160.0M | ||
| Q4 24 | $22.7M | $158.3M | ||
| Q3 24 | $21.2M | $160.8M | ||
| Q2 24 | $17.9M | $155.9M | ||
| Q1 24 | $23.0M | $155.6M |
总资产FBIORVSB
| Q4 25 | $185.5M | $1.5B | ||
| Q3 25 | $181.4M | $1.5B | ||
| Q2 25 | $159.9M | $1.5B | ||
| Q1 25 | $178.1M | $1.5B | ||
| Q4 24 | $144.2M | $1.5B | ||
| Q3 24 | $127.1M | $1.5B | ||
| Q2 24 | $145.7M | $1.5B | ||
| Q1 24 | $164.6M | $1.5B |
负债/权益比FBIORVSB
| Q4 25 | 1.05× | — | ||
| Q3 25 | 0.86× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 2.53× | — | ||
| Q4 24 | 2.55× | — | ||
| Q3 24 | 2.48× | — | ||
| Q2 24 | 3.75× | — | ||
| Q1 24 | 2.67× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-12.5M | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-736.0K |
| 自由现金流率自由现金流/营收 | — | -5.2% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | — | $20.4M |
8季度趋势，按日历期对齐
经营现金流FBIORVSB
| Q4 25 | $-12.5M | $-506.0K | ||
| Q3 25 | $-6.1M | $16.8M | ||
| Q2 25 | $-27.6M | $-697.0K | ||
| Q1 25 | $-19.6M | $8.3M | ||
| Q4 24 | $-12.9M | $2.2M | ||
| Q3 24 | $-20.1M | $764.0K | ||
| Q2 24 | $-21.8M | $5.4M | ||
| Q1 24 | $-25.4M | $12.8M |
自由现金流FBIORVSB
| Q4 25 | — | $-736.0K | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | — | $-773.0K | ||
| Q1 25 | — | $5.6M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | — | $7.1M |
自由现金流率FBIORVSB
| Q4 25 | — | -5.2% | ||
| Q3 25 | — | 120.1% | ||
| Q2 25 | — | -5.8% | ||
| Q1 25 | — | 43.1% | ||
| Q4 24 | — | 15.0% | ||
| Q3 24 | — | -11.3% | ||
| Q2 24 | — | 43.7% | ||
| Q1 24 | — | 79.0% |
资本支出强度FBIORVSB
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 21.0% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | 0.0% | 17.3% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 62.0% |
现金转化率FBIORVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | -1.04× | 15.25× | ||
| Q2 25 | -1.78× | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
